Mesoporous silica with precisely controlled pores reduces food efficiency and suppresses weight gain in mice

Mia Rinde1, Natalia Kupferschmidt1, Muhammad Naeem Iqbal2

  • 1Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, SE-106 91, Stockholm, Sweden.

Insights

Certain mesoporous silica particles (MSPs) effectively reduced obesity and improved metabolic health in mice. These findings suggest MSPs could be a novel therapeutic strategy for metabolic disorders.

Area of Science:

  • Materials Science
  • Biomedical Engineering
  • Nanotechnology

Background:

  • Obesity is a significant risk factor for cardiovascular disease and diabetes.
  • Metabolic dysregulation associated with obesity requires novel therapeutic interventions.
  • Mesoporous silica particles (MSPs) offer tunable properties for potential biomedical applications.

Purpose of the Study:

  • To investigate the impact of distinct mesoporous silica particles (MSPs) on metabolic parameters in a diet-induced obesity mouse model.
  • To determine if MSPs, when supplemented in food, can modulate weight, adiposity, and key metabolic markers.
  • To compare the efficacy of different MSPs with controlled pore sizes in mitigating obesity-related health issues.

Main Methods:

  • Synthesis and characterization of MSPs with precisely controlled pore sizes.
  • Administration of MSPs via diet to C57Bl/6 mice fed a high-fat diet to induce obesity.
  • Assessment of body weight, adipose tissue mass, leptin levels, and food efficiency in MSP-treated and control groups.

Main Results:

  • The most effective MSPs significantly reduced adipose tissue formation (6.5 ± 0.5 g vs. 9.4 ± 1.2 g in controls).
  • Leptin levels were nearly halved in mice treated with effective MSPs (16.9 ± 1.9 ng/ml vs. 32.8 ± 7.4 ng/ml).
  • A 33% reduction in food efficiency was observed with the most effective MSPs, while control MSPs showed no significant effects.

Conclusions:

  • Distinct mesoporous silica particles demonstrate potential in improving metabolic risk factors associated with obesity.
  • The study highlights the therapeutic promise of specifically engineered MSPs for metabolic health.
  • Further research is warranted to elucidate the mechanism of action and confirm the safety of MSPs for human application.

Related Concept Videos